Attach up to 3 Basic Fighting Energy cards from your discard pile to your Benched Pokémon in any way you like.
During your next turn, this Pokémon can't use Mega Brave.
Mega Evolution was released in 2025. It belongs to the Mega Evolution series.
Set size is 188 cards, which categorizes Mega Evolution as large. As of 2026, the set is 1 year old and still in a recent release window.
In the Mega Evolution checklist, Mega Lucario ex occupies position #160 as a Ultra Rare card.
Mega Lucario ex is a Mega Evolution card from the 2025 release window. Its card type is Pokémon.
The rarity label is Ultra Rare. Printed HP is 340.
Energy typing is Fighting. This gives collectors a clear identity footprint for the print.
This card evolves from Riolu. Card rules text: Mega Evolution ex Rule: When your Mega Evolution Pokémon ex is Knocked Out, your opponent takes 3 Prize cards.
For Mega Lucario ex in Mega Evolution, the current reference price is $15.20. Price action is stable over 7 days, moving only +1.0%.
That is close to the 30-day average of $15.08. The 90-day window shows a floor near $13.26 and a peak around $15.72 (16% total spread), which maps to low-volatility movement.
Rarity classification for this copy is Ultra Rare.
Mega Lucario ex sits within a broader pool of Mega variants that can be compared by set, rarity, and price. Comparable entries in this snapshot: 5 cards, 3 distinct sets.
Observed alternatives run from $1.30 to $274.27 (20998% spread). The current card sits -82% versus the sampled alternative average of $86.67.
Notable alternatives include Mega Lucario ex #12 (Mega Evolution Black Star Promos) at $1.38, Mega Lucario ex #113 (Ascended Heroes) at $1.37, Mega Lucario ex #179 (Mega Evolution) at $155.01, and Mega Lucario ex #188 (Mega Evolution) at $274.27.
Pricing context for collectors: We observe a +1.0% shift this week, which points toward price consolidation rather than immediate volatility. Observed 90-day bounds of $13.26 and $15.72 create a 16% band, matching a low-volatility profile.
Relative to the 30-day baseline ($15.08), pricing is near equilibrium. Graded context points to a substantial premium curve, with PSA 10 at +445% above raw pricing.
PSA 9 is currently around $29.87, while PSA 10 is $82.80.
